Climb Bio to Present at Guggenheim 3rd Annual Healthcare Innovation Conference
Globe Newswire•02/11/2026•07:00 ET
0
Key Highlights
- ➤Climb Bio (CLYM) executives to participate in Guggenheim Healthcare Innovation Conference
- ➤Fireside chat scheduled for November 9 at 4:00 p.m. ET
- ➤Pipeline includes budoprutug and CLYM116 for immune-mediated diseases
WELLESLEY HILLS, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming investor conference detailed below.
Guggenheim 3rd Annual Healthcare Innovation Conference Format: Fireside Chat Date: Monday, November 9 Time: 4:00 – 4:25 p.m. ET
Get started
Create a free account to read the full story.